The U.S. Copyright Royalty Board has announced new mechanical royalty rates for the creative side of the music industry -- songrwriters and music publishers. The new rates apply to 2026 and 2027. They ...

CRB-913 was safe and well-tolerated across all doses studied Daily neuropsychiatric assessments using CSSRS, PHQ-9, and GAD-7 were negative for all participants A placebo-adjusted mean weight loss of ...

(RTTNews) - Corbus Pharmaceuticals Holdings Inc. (CRBP) has announced favorable results from its Phase 1a study of CRB-913, an oral CB1 inverse agonist being developed for chronic obesity management.

KANSAS CITY, Mo., Nov. 25, 2025 (GLOBE NEWSWIRE) -- CRB, a leading provider of integrated project delivery solutions for the food and beverage manufacturing industry, today announced the appointment ...